Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
4
NMPA:4
Drug Approvals
Rivastigmine Transdermal Patch
- Product Name
- 利斯的明透皮贴剂
- Approval Number
- 国药准字H20254469
- Approval Date
- Jun 10, 2025
NMPA
Tofacitinib Citrate Tablets
- Product Name
- 枸橼酸托法替布片
- Approval Number
- 国药准字H20243419
- Approval Date
- Mar 29, 2024
NMPA
Afatinib Dimaleate Tablets
- Product Name
- 马来酸阿法替尼片
- Approval Number
- 国药准字H20234061
- Approval Date
- Aug 29, 2023
NMPA
Afatinib Dimaleate Tablets
- Product Name
- 马来酸阿法替尼片
- Approval Number
- 国药准字H20234060
- Approval Date
- Aug 29, 2023
NMPA
Clinical Trials
No trials found
News
No news found